Features, pricing, ratings, and pros & cons — compared head-to-head.
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial endpoint protection platform tool by 360 Security Group (Qihoo 360). Deep Instinct DSX is a commercial endpoint protection platform tool by Deep Instinct. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
360 High-Risk Vulnerability Immunization Tool V2.0
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
Mid-market and enterprise teams drowning in endpoint alert noise should evaluate Deep Instinct DSX for its pre-execution blocking model, which stops threats before they run rather than after. The neural network trained on hundreds of millions of samples delivers verdicts in under 20 milliseconds with a sub-0.1% false positive rate, meaning your SOC actually investigates real incidents. Skip this if your organization relies heavily on behavioral detection or needs mature EDR-style threat hunting; DSX prioritizes prevention over forensic depth, and NIST coverage skews toward Continuous Monitoring over post-breach response.
Tool that immunizes Windows systems against critical vulnerabilities
Deep learning-based malware prevention platform for endpoint protection
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs Deep Instinct DSX for your endpoint protection platform needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..
Deep Instinct DSX: Deep learning-based malware prevention platform for endpoint protection. built by Deep Instinct. Core capabilities include Deep learning-based malware prevention, Pre-execution threat blocking, Zero-day threat detection..
Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.
360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Deep Instinct DSX differentiates with Deep learning-based malware prevention, Pre-execution threat blocking, Zero-day threat detection.
360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Deep Instinct DSX is developed by Deep Instinct. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.
360 High-Risk Vulnerability Immunization Tool V2.0 and Deep Instinct DSX serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Zero Day. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox